ResApp Health (ASX: RAP) Share Price and News
Price
–
Movement
– ( )
(20 mins delayed)
52 Week Range
– - –
1 Year Return
ResApp Health Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
–
Day Change
– ( )
52 Week Range
– - –
Yesterday's Close
–
Today's Open
–
Days Range
– - –
Volume
–
Avg. Volume (1 month)
–
Turnover
–
Should you invest $1,000 in Resapp Health right now?
Before you buy Resapp Health shares, consider this:
Motley Fool investing expert Scott Phillips just revealed what he believes are the
The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*
And right now, Scott thinks there are 5 stocks that may be better buys...
See The 5 Stocks *Returns as of 3 April 2025
ResApp Health (ASX: RAP)
Latest News
Share Gainers
Why Afterpay, Piedmont Lithium, ResApp, & Santos are charging higher
Share Gainers
ResApp (ASX:RAP) share price jumps 19% on AstraZeneca deal
Share Gainers
ResApp (ASX:RAP) share price jumps on COVID-19 app plans
Share Gainers
Why Flight Centre, Qantas, ResApp, & Volpara are racing higher
Share Market News
Why the ResApp (ASX:RAP) share price is sinking 5% today
Share Market News
Why the ResApp (ASX:RAP) share price opened 10% higher today
Share Market News
Here's why the Resapp (ASX:RAP) share price closed 5% lower
Share Market News
Why the ResApp (ASX:RAP) share price is climbing higher
Share Market News
Here's why the ResApp (ASX:RAP) share price is climbing 6%
Share Market News
Why the ResApp (ASX:RAP) share price is edging higher
Share Market News
Why the Resapp (ASX:RAP) share price stormed 5% higher today
Share Market News
Why the ResApp (ASX:RAP) share price is falling 18% lower today
RAP ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|
About ResApp Health
ResApp is developing digital healthcare solutions to assist doctors and empower patients to diagnose and manage respiratory disease. We are creating easy to use, affordable, clinically-validated and regulatory-approved diagnostic tools that only require a smartphone. Our solutions are designed to be easily integrated into existing telehealth solutions and we are also working on apps to provide respiratory disease diagnosis and management directly to consumers and healthcare providers. ###Narhex Life Sciences Ltd has completed the acquisition of ResApp Diagnostics Pty Ltd and will now change its name to ResApp Health.###